ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.027,59
0,00%
S&P 500
5.308,15
0,00%
US Dollar vs BRL
5,1092
-0,50%
Bitcoin
66.295,61
0,05%
Brent Oil
83,02
0,44%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Travere Therapeutics Inc (TVTX)

  7. Travere Therapeutics Inc (TVTX) Notícias

TVTX Travere Therapeutics Inc

6,80
0,00 (0,00%)
Pré-mercado
Última atualização: 09:28:39
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Travere Therapeutics Inc TVTX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,00 0,00% 6,80 09:28:39
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
6,80
mais cotações »

Notícias Recentes

Data Hora Fonte Título
15/05/202418:00GLOBETravere Therapeutics Reports Inducement Grants Under Nasdaq..
09/05/202417:30GLOBETravere Therapeutics to Present at National Kidney..
08/05/202417:30GLOBETravere Therapeutics to Present at Upcoming Investor..
06/05/202417:01GLOBETravere Therapeutics Reports First Quarter 2024 Financial..
29/04/202417:30GLOBETravere Therapeutics to Report First Quarter 2024 Financial..
24/04/202408:05GLOBETravere Therapeutics and CSL Vifor Announce European..
24/04/202404:00PRNUSCSL Vifor and Travere Therapeutics Announce European..
04/04/202417:30GLOBETravere Therapeutics to Present Abstracts at the Society for..
03/04/202417:30GLOBETravere Therapeutics to Present Abstracts on FILSPARI®..
13/03/202418:00GLOBETravere Therapeutics Reports Inducement Grants Under Nasdaq..
11/03/202408:05GLOBETravere Therapeutics Submits Supplemental New Drug..
26/02/202418:30GLOBETravere Therapeutics to Present at Upcoming Investor..
23/02/202409:05GLOBETravere Therapeutics and CSL Vifor Announce Sparsentan..
23/02/202404:00PRNUSCSL Vifor and Travere Therapeutics announce sparsentan..
15/02/202418:01GLOBETravere Therapeutics Reports Fourth Quarter and Full Year..
08/02/202418:30GLOBETravere Therapeutics to Report Fourth Quarter and Full Year..
01/02/202418:30GLOBETravere Therapeutics to Present at the Guggenheim 6th Annual..
25/01/202418:05GLOBETravere Therapeutics Announces Licensing Agreement with..
08/01/202409:00GLOBETravere Therapeutics Provides Corporate Update and 2024..
02/01/202418:30GLOBETravere Therapeutics to Present at the 42nd Annual J.P...
14/12/202309:30GLOBETravere Therapeutics Initiates Pivotal Phase 3 Clinical..
04/12/202319:14DJNTravere Shares Rise 8.4%; Co. To Cut Staff, Focus on IgAN,..
04/12/202318:05GLOBETravere Completes Successful pre-NDA Meeting for FILSPARI in..
21/11/202318:30GLOBETravere Therapeutics to Present at the 6th Annual Evercore..
07/11/202318:01GLOBETravere Therapeutics Reports Third Quarter 2023 Financial..
03/11/202311:46GLOBETravere Therapeutics Announces Late-Breaking Data from Phase..
24/10/202317:30GLOBETravere Therapeutics to Report Third Quarter 2023 Financial..
13/10/202317:30GLOBETravere Therapeutics to Present Abstracts at the American..
11/10/202318:00GLOBETravere Therapeutics Reports Inducement Grants Under Nasdaq..
26/09/202317:30GLOBETravere Therapeutics to Present Abstracts at the 17th..
21/09/202308:30GLOBETravere Therapeutics Announces Confirmatory Data from the..
11/09/202318:00GLOBETravere Therapeutics Reports Inducement Grants Under..
05/09/202309:30GLOBETravere Therapeutics Completes Sale of Bile Acid Product..
31/08/202317:30GLOBETravere Therapeutics to Present at the 2023 Wells Fargo..
24/08/202317:30GLOBETravere Therapeutics to Present Abstracts at the Society for..
14/08/202318:00GLOBETravere Therapeutics Reports Inducement Grants Under Nasdaq..
03/08/202317:01GLOBETravere Therapeutics Reports Second Quarter 2023 Financial..
20/07/202317:30GLOBETravere Therapeutics to Report Second Quarter 2023 Financial..
17/07/202309:00GLOBETravere Therapeutics Enters Agreement to Sell its Bile Acid..
11/07/202318:00GLOBETravere Therapeutics Reports Inducement Grants Under Nasdaq..
06/07/202306:45PRNUSINVESTIGATION ALERT: The Gross Law Firm Notifies..
30/06/202306:45PRNUSTVTX FRAUD ALERT: Jakubowitz Law is Investigating Travere..
28/06/202306:45PRNUSINVESTIGATION ALERT: The Gross Law Firm Notifies..
23/06/202306:45PRNUSTVTX FRAUD ALERT: Jakubowitz Law is Investigating Travere..
14/06/202318:00GLOBETravere Therapeutics Reports Inducement Grants Under Nasdaq..
08/06/202317:30GLOBETravere Therapeutics Announces Presentations of Abstracts at..
31/05/202308:00GLOBETravere Therapeutics Announces Positive Topline Results from..

Seu Histórico Recente

NASDAQ
TVTX
Travere Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados